Refine by
Genomic Profiling Services In Usa
12 services found
by:Decipher Biosciences Inc. based inSan Diego, CALIFORNIA (USA)
Decipher Bladder is the only genomic subtyping tool available to physicians in the United States treating patients with locally advanced bladder ...
by:Lucence Health Inc. based inPalo Alto, CALIFORNIA (USA)
Tissue500™ is a comprehensive genomic profiling test that detects clinically relevant mutations in 572 genes to identify a patient’s unique cancer ...
Manufactured by:Foundation Medicine, Inc. based inCambridge, MASSACHUSETTS (USA)
Discover tissue AND blood-based FDA-approved comprehensive genomic profiling testing for all solid tumors with FoundationOne®CDx and FoundationOne®Liquid CDx. In addition, FoundationOne®Heme is a laboratory developed test for hematologic malignancies, sarcomas, or solid tumors where fusion detection is desired. ...
Manufactured by:Foundation Medicine, Inc. based inCambridge, MASSACHUSETTS (USA)
Ranging from interpretation of results on each report to expert consultations and ongoing education, these services can help you make the most of comprehensive genomic profiling (CGP) in your ...
Manufactured by:Foundation Medicine, Inc. based inCambridge, MASSACHUSETTS (USA)
Our genomic information knowledgebase is continuously evolving, informed by every clinical sample sequenced with Foundation Medicine’s comprehensive genomic profiling tests. You can also access a unique clinicogenomic data set through our partnership with Flatiron Health, a leading provider of clinical ...
by:Lucence Health Inc. based inPalo Alto, CALIFORNIA (USA)
LiquidHALLMARK® is an ultrasensitive next-generation sequencing assay for genomic profiling of a patient’s unique cancer. By requiring only a single blood sample, LiquidHALLMARK provides important information for cancer care especially when tissue by invasive biopsy is insufficient or ...
by:Thermo Fisher Scientific, LIMS & Laboratory Software based inPhiladelphia, PENNSYLVANIA (USA)
Available immediately through June 30, 2021, gain subsidized access to easy NGS through the GlobalAccess Sequencing Program. Designed to accelerate multi-institutional-led studies focused on SARS-CoV-2 research, this program will also support labs facing significant constraints as a result of the global crisis by offering faster access to comprehensive molecular profiling. Our latest sequencing ...
Manufactured by:Foundation Medicine, Inc. based inCambridge, MASSACHUSETTS (USA)
Simplified test results provide information about genomic findings and biomarkers and their associated targeted therapies when available. We also provide information on clinically relevant alterations and available clinical trial options specific to each patient’s ...
Manufactured by:Foundation Medicine, Inc. based inCambridge, MASSACHUSETTS (USA)
Foundation Medicine matches patients to precision oncology trials based on genomic alterations, tumor type, and age. Our team of expert curators and genomicists helps facilitate awareness of genomically matched clinical trial options for your ...
Manufactured by:MedGenome Inc. based inCounty of New Castle, DELAWARE (USA)
A comprehensive suite of bioinformatics services for NGS data analysis encompassing a wide range of applications including genomics, transcriptomics, single cell genomics, immune profiling, genome assembly and annotation and more. Our team of experts combined with our advanced reporting have resulted in over 200 scientific ...
by:NeoGenomics Laboratories based inFort Myers, FLORIDA (USA)
Our genomics laboratories in La Jolla, California (formerly Human Longevity Oncology), and Houston, Texas (formerly SeqWright Genomics), are outfitted for high throughput genomics. In addition to our molecular menu of validated assays spanning next-generation sequencing (NGS), DNA microarrays, qPCR/ddPCR, Sanger sequencing, NanoString, and liquid biopsy, we provide fully customizable, rapid assay ...
by:SOPHiA Genetics based inBoston, MASSACHUSETTS (USA)
Unlocking the potential of precision medicine with Artificial Intelligence – enabled data-driven insights. Advance targeted therapy development by harnessing the power of data and multimodal analytics. Advances in molecular and imaging techniques have resulted in an explosion of data, providing an unprecedented opportunity to identify clinically relevant drug targets. Yet, deciphering and ...